Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis
- First Posted Date
- 2022-03-07
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- Meiji Pharma USA Inc.
- Target Recruit Count
- 132
- Registration Number
- NCT05268016
- Locations
- 🇺🇸
Northwest Arkansas Clinical Trials Center, Rogers, Arkansas, United States
🇺🇸University of Southern California, Los Angeles, California, United States
🇺🇸Colorado Medical Research Center, Inc., Denver, Colorado, United States
News
No news found